Pharmacogenomics: current status and future perspectives

M Pirmohamed - Nature Reviews Genetics, 2023 - nature.com
Inter-individual variability in drug response, be it efficacy or safety, is common and likely to
become an increasing problem globally given the growing elderly population requiring …

[HTML][HTML] Integrative toxicogenomics: Advancing precision medicine and toxicology through artificial intelligence and OMICs technology

AV Singh, V Chandrasekar, N Paudel, P Laux… - Biomedicine & …, 2023 - Elsevier
More information about a person's genetic makeup, drug response, multi-omics response,
and genomic response is now available leading to a gradual shift towards personalized …

[HTML][HTML] Supervised machine learning in drug discovery and development: Algorithms, applications, challenges, and prospects

G Obaido, ID Mienye, OF Egbelowo… - Machine Learning with …, 2024 - Elsevier
Drug discovery and development is a time-consuming process that involves identifying,
designing, and testing new drugs to address critical medical needs. In recent years, machine …

[HTML][HTML] Drug-microbiota interactions: an emerging priority for precision medicine

Q Zhao, Y Chen, W Huang, H Zhou… - Signal Transduction and …, 2023 - nature.com
Individual variability in drug response (IVDR) can be a major cause of adverse drug
reactions (ADRs) and prolonged therapy, resulting in a substantial health and economic …

Pharmacogenomics beyond single common genetic variants: the way forward

VM Lauschke, Y Zhou… - Annual Review of …, 2024 - annualreviews.org
Interindividual variability in genes encoding drug-metabolizing enzymes, transporters,
receptors, and human leukocyte antigens has a major impact on a patient's response to …

[HTML][HTML] Artificial intelligence in public health: current trends and future possibilities

D Giansanti - International Journal of Environmental Research and …, 2022 - mdpi.com
3. It must behave (act and think) in a rational way: the method that leads the intelligent
system to solve a problem is a formal structured process following the logic. 4. It must obtain …

High-throughput assays to assess variant effects on disease

K Ma, LO Gauthier, F Cheung… - Disease Models & …, 2024 - journals.biologists.com
Interpreting the wealth of rare genetic variants discovered in population-scale sequencing
efforts and deciphering their associations with human health and disease present a critical …

Clinical implementation of rare and novel DPYD variants for personalizing fluoropyrimidine treatment: challenges and opportunities

E De Mattia, N Milan, YG Assaraf… - … Journal of Biological …, 2024 - pmc.ncbi.nlm.nih.gov
Fluoropyrimidines (FLs)[5-Fluorouracil, Capecitabine] are used in the treatment of several
solid tumors. Dihydropyrimidine dehydrogenase (DPD) is the rate-limiting enzyme for FL …

Integrating rare genetic variants into DPYD pharmacogenetic testing may help preventing fluoropyrimidine-induced toxicity

R Larrue, S Fellah, B Hennart, N Sabaouni… - The …, 2024 - nature.com
Variability in genes involved in drug pharmacokinetics or drug response can be responsible
for suboptimal treatment efficacy or predispose to adverse drug reactions. In addition to …

The 75-Year Anniversary of the Department of Physiology and Pharmacology at Karolinska Institutet—Examples of Recent Accomplishments and Future Perspectives

E Weitzberg, M Ingelman-Sundberg… - Pharmacological …, 2024 - Elsevier
Karolinska Institutet is a medical university encompassing 21 departments distributed across
three departmental or campus groups. Pharmacological research has a long and successful …